X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (48) 48
index medicus (47) 47
female (44) 44
hiv (41) 41
infectious diseases (40) 40
adult (33) 33
human immunodeficiency virus--hiv (33) 33
hiv infections - drug therapy (30) 30
immunology (27) 27
male (27) 27
antiretroviral therapy (25) 25
africa (22) 22
aids/hiv (20) 20
acquired immune deficiency syndrome--aids (19) 19
cote d'ivoire (19) 19
drug therapy (19) 19
research article (19) 19
cd4 lymphocyte count (17) 17
hiv infection (17) 17
mortality (17) 17
virus diseases (17) 17
middle aged (15) 15
aids (14) 14
health aspects (14) 14
life sciences (14) 14
prevalence (14) 14
sub-saharan africa (14) 14
anti-hiv agents - therapeutic use (13) 13
antiretroviral drugs (13) 13
children (13) 13
pregnancy (13) 13
santé publique et épidémiologie (13) 13
west africa (13) 13
adults (12) 12
collaboration (12) 12
epidemiology (12) 12
highly active antiretroviral therapy (12) 12
research (12) 12
[sdv.spee]life sciences [q-bio]/santé publique et épidémiologie (11) 11
antiviral agents (11) 11
hiv infections - complications (11) 11
hiv infections - epidemiology (11) 11
infant, newborn (11) 11
infections (11) 11
prevention (11) 11
studies (11) 11
analysis (10) 10
cote d'ivoire - epidemiology (10) 10
cross-sectional studies (10) 10
hiv infections - virology (10) 10
patients (10) 10
risk factors (10) 10
[ sdv.spee ] life sciences [q-bio]/santé publique et épidémiologie (9) 9
hiv-2 (9) 9
transmission (9) 9
antiretroviral agents (8) 8
article (8) 8
child (8) 8
child, preschool (8) 8
cohort studies (8) 8
cote-divoire (8) 8
infant (8) 8
nevirapine (8) 8
screening (8) 8
therapy (8) 8
viral load (8) 8
women (8) 8
cohort (7) 7
diagnosis (7) 7
disease transmission (7) 7
hiv/aids (7) 7
human immunodeficiency virus (7) 7
retrospective studies (7) 7
treatment outcome (7) 7
virology (7) 7
acquired immune deficiency syndrome (6) 6
adolescent (6) 6
anti-hiv agents - administration & dosage (6) 6
anti-retroviral agents - therapeutic use (6) 6
cervical cancer (6) 6
cotrimoxazole (6) 6
hbv (6) 6
hiv infections - diagnosis (6) 6
infectious disease transmission, vertical - prevention & control (6) 6
malaria (6) 6
pediatrics (6) 6
population (6) 6
prospective studies (6) 6
risk (6) 6
womens health (6) 6
[sdv]life sciences [q-bio] (5) 5
acceptability (5) 5
africa, western (5) 5
africa, western - epidemiology (5) 5
cancer (5) 5
cd4 antigen (5) 5
dosage and administration (5) 5
hepatitis b (5) 5
hiv infections - immunology (5) 5
hiv infections - prevention & control (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet, ISSN 0140-6736, 03/2018, Volume 391, Issue 10123, pp. 835 - 836
[...]more detailed data from western Africa than are available are required to guide implementation of hepatitis care strategies and national action plans. The... 
AFRICA | MEDICINE, GENERAL & INTERNAL | HIV Infections | Hepatitis | Prevalence | Hepatitis C | Health Resources | Humans | Systematic review | Acquired immune deficiency syndrome--AIDS | Epidemiology | Human immunodeficiency virus--HIV
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2015, Volume 10, Issue 6, p. e0129886
Journal Article
PLoS Medicine, ISSN 1549-1277, 2007, Volume 4, Issue 8, pp. 1362 - 1373
Background Highly active antiretroviral treatment ( HAART) has only been recently recommended for HIV-infected pregnant women requiring treatment for their own... 
SINGLE-DOSE NEVIRAPINE | MEDICINE, GENERAL & INTERNAL | MOTHER-TO-CHILD | LOW-BIRTH-WEIGHT | COTE-DIVOIRE | IMMUNODEFICIENCY-VIRUS TYPE-1 | BREAST-FED CHILDREN | RANDOMIZED-TRIAL | PREGNANT-WOMEN | VERTICAL TRANSMISSION | ORAL ZIDOVUDINE | HIV-1 | HIV Infections - prevention & control | Lamivudine - administration & dosage | Follow-Up Studies | Humans | Antiretroviral Therapy, Highly Active - adverse effects | Infant | Male | Nevirapine - therapeutic use | Cote d'Ivoire - epidemiology | Viral Load | Zidovudine - administration & dosage | Anti-HIV Agents - administration & dosage | Antiretroviral Therapy, Highly Active - utilization | Lamivudine - therapeutic use | Anti-HIV Agents - therapeutic use | Female | HIV Infections - transmission | Infant, Newborn | Infant, Low Birth Weight | Anti-HIV Agents - adverse effects | HIV Infections - congenital | CD4 Lymphocyte Count | Pregnancy | Puerperal Disorders - drug therapy | Breast Feeding - adverse effects | Pregnancy Complications, Infectious - drug therapy | HIV Infections - drug therapy | Zidovudine - therapeutic use | Program Evaluation | Nevirapine - administration & dosage | Infectious Disease Transmission, Vertical - prevention & control | Cohort Studies | Prevention | Antiviral agents | Disease transmission | Pregnant women | Dosage and administration | HIV infection in children | Drug therapy | HIV infection | Health aspects | Methods | Acquired immune deficiency syndrome--AIDS | Womens health | Human immunodeficiency virus--HIV | Life Sciences | Santé publique et épidémiologie | Public Health and Epidemiology | Medicine in Developing Countries | Cohort studies | Infectious Diseases | AIDS | Infants | HIV Infection | HIV | Acquired immune deficiency syndrome | Human immunodeficiency virus
Journal Article
BMC Infectious Diseases, ISSN 1471-2334, 07/2017, Volume 17, Issue 1, pp. 466 - 8
Background: In West Africa where HIV-1 and HIV-2 co-circulate, the co-infection with hepatitis B virus (HBV) and hepatitis Delta virus (HDV) is not well... 
HIV-2 | HBV and HDV coinfection | HBV | West Africa | VIRAL LOAD | LAMIVUDINE TREATMENT | INFECTIOUS DISEASES | COINFECTION | ANTIRETROVIRAL THERAPY | HUMAN-IMMUNODEFICIENCY-VIRUS | IVORY-COAST | INFECTED PATIENTS | COHORT | EPIDEMIOLOGY | TENOFOVIR | HIV-1 - pathogenicity | Prevalence | Follow-Up Studies | Hepatitis B virus - pathogenicity | HIV Infections - epidemiology | Humans | Middle Aged | Hepatitis B - virology | Hepatitis B - epidemiology | Male | Cote d'Ivoire - epidemiology | Hepatitis Delta Virus - pathogenicity | Mali - epidemiology | HIV-2 - pathogenicity | Adult | Female | Hepatitis Delta Virus - genetics | Burkina Faso - epidemiology | Cross-Sectional Studies | HIV Infections - virology | Risk Factors | CD4 Lymphocyte Count | Coinfection - epidemiology | AIDS-Related Opportunistic Infections - epidemiology | Hepatitis B virus - genetics | Delta-associated agent | Analysis | Research | Hepatitis B virus | HIV (Viruses) | Risk factors | Prevalence studies (Epidemiology) | Enzymes | Hepatitis B surface antigen | Health risks | Viruses | Infections | Serology | Risk analysis | Epidemiology | Patients | Blood | Antiretroviral therapy | CD4 antigen | Studies | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Hepatology | Human immunodeficiency virus--HIV | Gastroenterology | Interferon | DNA testing | Deoxyribonucleic acid--DNA | Hepatitis B | Hepatitis delta virus
Journal Article
Tropical Medicine & International Health, ISSN 1360-2276, 09/2017, Volume 22, Issue 9, pp. 1186 - 1195
Introduction Cotrimoxazole (CTX) should be given to all HIV‐infected adults with mild or severe HIV‐disease or those with CD4 counts below 350/mm3 according to... 
paludisme | HIV | VIH | Afrique de l'Ouest | West Africa | adults | cotrimoxazole | África Occidental | adultos | malaria | adultes | cotrimoxazol | MORTALITY | COTE-DIVOIRE | ANTIRETROVIRAL THERAPY | TRIMETHOPRIM-SULFAMETHOXAZOLE PROPHYLAXIS | PREVALENCE | PLASMODIUM-FALCIPARUM MALARIA | HIV-1-INFECTED ADULTS | TROPICAL MEDICINE | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | INSECTICIDE-TREATED BEDNETS | PREGNANT-WOMEN | CELL COUNT | HIV-1 | Multivariate Analysis | HIV Infections - virology | Humans | Proportional Hazards Models | Male | Risk | Antimalarials - therapeutic use | CD4 Lymphocyte Count | Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use | Incidence | Malaria - prevention & control | Malaria - epidemiology | HIV Infections - complications | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | Malaria - complications | Africa, Western | Cohort Studies | Prevention | Highly active antiretroviral therapy | Antiviral agents | Malaria | Analysis | Adults | HIV (Viruses) | Drug therapy | HIV infection | Therapy | Countries | Prophylaxis | Transmission | Multivariate analysis | Risks | Reduction | Antiretroviral agents | Human immunodeficiency virus--HIV | Cotrimoxazole | Public health | Vector-borne diseases | Antiretroviral drugs | Human diseases | Cohorts | Health risks | Hazards | Patients | Cells | Antiretroviral therapy | CD4 antigen | Disease transmission | Inscriptions
Journal Article
Journal Article
by Ekouevi, Didier K and Balestre, Eric and Coffie, Patrick A and Minta, Daouda and Messou, Eugene and Sawadogo, Adrien and Minga, Albert and Sow, Papa Salif and Bissagnene, Emmanuel and Eholie, Serge P and Gottlieb, Geoffrey S and Dabis, François and Zannou, Djimon Marcel and Ahouada, Carin and Akakpo, Jocelyn and Ahomadegbé, Christelle and Bashi, Jules and Gougounon-Houéto, Alice and Azon-Kouanou, Angèle and Houngbé, Fabien and Koumakpaï, Sikiratou and Alihonou, Florence and D'Almeida, Marcelline and Hodonou, Irvine and Hounhoui, Ghislaine and Sagbo, Gracien and Tossa-Bagnan, Leïla and Adjide, Herman and Drabo, Joseph and Bognounou, René and Dienderé, Arnaud and Traore, Eliezer and Zoungrana, Lassane and Zerbo, Béatrice and Sawadogo, Adrien Bruno and Zoungrana, Jacques and Héma, Arsène and Soré, Ibrahim and Bado, Guillaume and Tapsoba, Achille and Yé, Diarra and Kouéta, Fla and Ouedraogo, Sylvie and Ouédraogo, Rasmata and Hiembo, William and Gansonré, Mady and Messou, Eugene and Gnokoro, Joachim Charles and Koné, Mamadou and Kouakou, Guillaume Martial and Bosse, Clarisse Amani and Brou, Kouakou and Assi, Achi Isidore and Chenal, Henri and Hawerlander, Denise and Soppi, Franck and Abo, Yao and Bomisso, Germain and Eholie, Serge P and Amego, Mensah Deborah Noelly and Andavi, Viviane and Diallo, Zelica and Ello, Frédéric and Tanon, Aristophane Koffi and Koule, Serge Olivier and Anzan, Koffi Charles and Guehi, Calixte and Aka, Edmond Addi and Issouf, Koffi Ladji and Kouakou, Jean-Claude and N'Gbeche, Marie-Sylvie and Touré, Pety and Avit-Edi, Divine and Kouakou, Kouadio and Moh, Magloire and Yao, Valérie Andoblé and Folquet, Madeleine Amorissani and Dainguy, Marie-Evelyne and Kouakou, Cyrille and Méa-Assande, Véronique Tanoh and Oka-Berete, Gladys and Zobo, Nathalie and Acquah, Patrick and Kokora, Marie-Berthe and Eboua, Tanoh François and Timité-Konan, Marguerite and Ahoussou, Lucrèce Diecket and Assouan, Julie Kebé and Sami, Mabéa Flora and Kouadio, Clémence and Renner, Lorna and Goka, Bamenla and Welbeck, Jennifer and Sackey, Adziri and Owiafe, Seth Ntiri and Wejse, Christian and Da Silva, Zacarias José and Paulo, Joao and Rodrigues, Amabelia and Da Silva, David and ... and IeDEA West Africa Collaboration and IeDEA West Africa collaboration
PLoS ONE, ISSN 1932-6203, 06/2013, Volume 8, Issue 6, p. e66135
Journal Article
Journal Article